PERENNIAL ALLERGIC RHINITIS
Clinical trials for PERENNIAL ALLERGIC RHINITIS explained in plain language.
Never miss a new study
Get alerted when new PERENNIAL ALLERGIC RHINITIS trials appear
Sign up with your email to follow new studies for PERENNIAL ALLERGIC RHINITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New allergy drug shows promise for kids in Long-Term trial
Symptom relief CompletedThis study looked at the long-term safety and effectiveness of TAU-284 (Bepotastine besilate) in children aged 7 to 15 with perennial allergic rhinitis (year-round allergies). Over 12 weeks, researchers tracked side effects and changes in nasal symptoms like sneezing, runny nose,…
Matched conditions: PERENNIAL ALLERGIC RHINITIS
Phase: PHASE3 • Sponsor: Tanabe Pharma Corporation • Aim: Symptom relief
Last updated May 17, 2026 13:54 UTC
-
Kids' allergy relief: daily or just when needed?
Symptom relief CompletedThis study looked at whether children with year-round allergies need to use a steroid nasal spray every day or only when symptoms bother them. Sixty-eight children aged 6 to 18 took part. The goal was to see if using the spray only as needed works just as well as daily use, while…
Matched conditions: PERENNIAL ALLERGIC RHINITIS
Phase: PHASE3 • Sponsor: Mahidol University • Aim: Symptom relief
Last updated May 15, 2026 11:56 UTC
-
New allergy drug shows promise for kids in major trial
Symptom relief CompletedThis study tested a medicine called TAU-284 in 473 children aged 7 to 15 with year-round allergic rhinitis (nasal allergies). The goal was to see if it reduces sneezing, runny nose, and stuffiness better than a placebo over two weeks. The trial also checked for side effects.
Matched conditions: PERENNIAL ALLERGIC RHINITIS
Phase: PHASE3 • Sponsor: Tanabe Pharma Corporation • Aim: Symptom relief
Last updated May 13, 2026 16:01 UTC
-
New allergy drug shows promise for kids in large trial
Symptom relief CompletedThis study tested a new drug called TAU-284 in 490 children aged 7 to 15 who have year-round nasal allergies (perennial allergic rhinitis). The goal was to see if the drug reduces sneezing, runny nose, and stuffiness better than a placebo over two weeks. Researchers also checked …
Matched conditions: PERENNIAL ALLERGIC RHINITIS
Phase: PHASE3 • Sponsor: Tanabe Pharma Corporation • Aim: Symptom relief
Last updated May 12, 2026 13:40 UTC